|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/00 | |
| A61K 39/35 | |||
| A61K 45/06 | |||
| A61K 39/39 |
| (11) | Number of the document | 3403667 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18165195.1 |
| Date of filing the European patent application | 2007-09-26 | |
| (97) | Date of publication of the European application | 2018-11-21 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-22 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 84740406 P | 2006-09-26 | US |
| (72) |
REED, Steven G., US
CARTER, Darrick, US
|
| (73) |
Infectious Disease Research Institute,
1616 Eastlake Ave. E Suite 400, Seattle, WA 98102,
US
|
| (54) | VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT |
| VACCINE COMPOSITION CONTAINING SYNTHETIC ADJUVANT |